You are here
,

GW Pharma cannabis drug set to hit market following DEA nod

  • Friday, 28 September 2018
  • Posted by Aftab Ahmad
  • 0 Comments
U.S.-listed shares of GW Pharmaceuticals rose 8 percent on Thursday as its marijuana-based treatment Epidiolex cleared the last hurdle after the Drug Enforcement Administration labeled the drug as having a low abuse potential.


from Reuters: Health News https://ift.tt/2xJXHJ5

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply